Literature DB >> 35940729

Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Jeremy Louissaint1, Sasha Deutsch-Link2, Elliot B Tapper3.   

Abstract

Entities:  

Keywords:  Cognitive Dysfunction; Encephalopathy; Liver Disease

Mesh：

Year:  2022        PMID： 35940729      PMCID： PMC9531320          DOI： 10.1016/j.cgh.2022.04.036

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   13.576


× No keyword cloud information.
  97 in total

1.  The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study.

Authors:  Vishwadeep Ahluwalia; James B Wade; F Gerard Moeller; Melanie B White; Ariel B Unser; Edith A Gavis; Richard K Sterling; R Todd Stravitz; Arun J Sanyal; Mohammad S Siddiqui; Puneet Puri; Velimir Luketic; Douglas M Heuman; Michael Fuchs; Scott Matherly; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2015-07-21       Impact factor: 5.799

2.  Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.

Authors:  Rahima A Bhanji; Carlos Moctezuma-Velazquez; Andres Duarte-Rojo; Maryam Ebadi; Sunita Ghosh; Christopher Rose; Aldo J Montano-Loza
Journal:  Hepatol Int       Date:  2018-06-07       Impact factor: 6.047

3.  Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue.

Authors:  Dympna Gallagher; Patrick Kuznia; Stanley Heshka; Jeanine Albu; Steven B Heymsfield; Bret Goodpaster; Marjolein Visser; Tamara B Harris
Journal:  Am J Clin Nutr       Date:  2005-04       Impact factor: 7.045

4.  Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis.

Authors:  Elliot B Tapper; Yesenia Risech-Neyman; Neil Sengupta
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-26       Impact factor: 11.382

5.  Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study.

Authors:  Francesca Campagna; Sara Montagnese; Sami Schiff; Manuela Ruzzoli; Anna Biancardi; Pamela Iannizzi; Pietro L Pujatti; Paolo Angeli; Angelo Gatta; Carlo Merkel; Gioacchino Leandro; Daniela Mapelli; Piero Amodio
Journal:  Liver Int       Date:  2014-07-23       Impact factor: 5.828

6.  Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States.

Authors:  Elliot B Tapper; Utibe R Essien; Zhe Zhao; Nneka N Ufere; Neehar D Parikh
Journal:  J Hepatol       Date:  2022-03-30       Impact factor: 30.083

7.  Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.

Authors:  Feng Su; Lei Yu; Kristin Berry; Iris W Liou; Charles S Landis; Stephen C Rayhill; Jorge D Reyes; George N Ioannou
Journal:  Gastroenterology       Date:  2015-10-30       Impact factor: 22.682

8.  Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.

Authors:  Javier Ampuero; Carmina Montoliú; Macarena Simón-Talero; Virginia Aguilera; Raquel Millán; Celina Márquez; Rodrigo Jover; María Carmen Rico; Carmen Sendra; Miguel Ángel Serra; Manuel Romero-Gómez
Journal:  J Gastroenterol Hepatol       Date:  2018-03       Impact factor: 4.029

9.  Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study.

Authors:  Jovan Julien; Turgay Ayer; Elliot B Tapper; Carolina Barbosa; William N Dowd; Jagpreet Chhatwal
Journal:  Hepatology       Date:  2022-01-24       Impact factor: 17.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.